Veterinary diagnostics
Read a lateral-flow test with a phone. Standardize the result, and see where disease is moving.
Veterinary practices run rapid tests every day. Someone reads the result by eye, writes a word in the chart, and nothing else survives. LateraDX builds both halves of a better version: multiplex assays that get more out of one sample, and a reader that turns a phone photograph into a measurement anyone can check afterwards.
Most rapid test results are never recorded as more than a word
Rapid tests are run millions of times a year at the bench, read by eye, and recorded — when they are recorded at all — as a single word in a chart. No image survives. Nothing aggregates.
Smartphone Networked Optical Workflow
SNOW turns a photograph into a measurement, and a measurement into a record
A phone photographs the cassette. SNOW finds the result window, measures each zone against the membrane around it, and files the reading with the patient, the clinic, the time and the place. No instrument on the bench, and nothing left only in someone's memory of a faint line.
The software is one part of the company
The reader is what a clinic can use today. The assays behind it are what the company is for.
The reader and the record
Software that reads the lateral-flow tests clinics already run — bands or spots, whatever the cassette — and keeps what it read.
Tick-borne and infectious disease
Vector-borne disease is expanding, guidelines call for annual screening, and the panel a clinic can run is fixed by whatever cartridge it bought.
Oncology and liquid biopsy
Rapid, blood-based tests for cancers that are currently found late, expensively, or both.
The data layer
Every reading carries a place and a time. Enough of them and you can see where a disease is moving, not only that the dog in front of you has it.
Where the science originates
LateraDX is an early-stage company built on multiplex lateral-flow and reader technology validated through research conducted at The Ohio State University. Two of the three executives hold appointments there, and the oncology biomarker work originates in peer-reviewed research from those labs.